Correlation Between Transcode Therapeutics and Incyte
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and Incyte, you can compare the effects of market volatilities on Transcode Therapeutics and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Incyte.
Diversification Opportunities for Transcode Therapeutics and Incyte
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Transcode and Incyte is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Incyte go up and down completely randomly.
Pair Corralation between Transcode Therapeutics and Incyte
Given the investment horizon of 90 days Transcode Therapeutics is expected to generate 3.02 times more return on investment than Incyte. However, Transcode Therapeutics is 3.02 times more volatile than Incyte. It trades about 0.0 of its potential returns per unit of risk. Incyte is currently generating about 0.0 per unit of risk. If you would invest 1,051 in Transcode Therapeutics on November 2, 2025 and sell it today you would lose (102.00) from holding Transcode Therapeutics or give up 9.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 98.36% |
| Values | Daily Returns |
Transcode Therapeutics vs. Incyte
Performance |
| Timeline |
| Transcode Therapeutics |
| Incyte |
Transcode Therapeutics and Incyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transcode Therapeutics and Incyte
The main advantage of trading using opposite Transcode Therapeutics and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.| Transcode Therapeutics vs. Gilead Sciences | Transcode Therapeutics vs. Sanofi ADR | Transcode Therapeutics vs. Amgen Inc | Transcode Therapeutics vs. GlaxoSmithKline PLC ADR |
| Incyte vs. United Therapeutics | Incyte vs. Genmab AS | Incyte vs. Royalty Pharma Plc | Incyte vs. Quest Diagnostics Incorporated |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |